These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7962045

  • 41. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
    Schwartz SM, Daling JR, Shera KA, Madeleine MM, McKnight B, Galloway DA, Porter PL, McDougall JK.
    J Clin Oncol; 2001 Apr 01; 19(7):1906-15. PubMed ID: 11283122
    [Abstract] [Full Text] [Related]

  • 42. Distribution of HPV genotypes in cervical cancer in multi- ethnic Malaysia.
    Hamzi Abdul Raub S, Isa NM, Zailani HA, Omar B, Abdullah MF, Mohd Amin WA, Noor RM, Ayub MC, Abidin Z, Kassim F, Vicknesh V, Zakaria Z, Kamaluddin MA, Tan GC, Syed Husain SN.
    Asian Pac J Cancer Prev; 2014 Apr 01; 15(2):651-6. PubMed ID: 24568473
    [Abstract] [Full Text] [Related]

  • 43. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping.
    Jones MW, Kounelis S, Papadaki H, Bakker A, Swalsky PA, Woods J, Finkelstein SD.
    Int J Gynecol Pathol; 2000 Apr 01; 19(2):110-7. PubMed ID: 10782406
    [Abstract] [Full Text] [Related]

  • 44. Physical status and expression of HPV genes in cervical cancers.
    Park JS, Hwang ES, Park SN, Ahn HK, Um SJ, Kim CJ, Kim SJ, Namkoong SE.
    Gynecol Oncol; 1997 Apr 01; 65(1):121-9. PubMed ID: 9103401
    [Abstract] [Full Text] [Related]

  • 45. Infrequent occurrence of high-risk human papillomavirus and of p53 mutation in minimal deviation adenocarcinoma of the cervix.
    Toki T, Zhai YL, Park JS, Fujii S.
    Int J Gynecol Pathol; 1999 Jul 01; 18(3):215-9. PubMed ID: 12090589
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
    Lo KW, Mok CH, Chung G, Huang DP, Wong F, Chan M, Lee JC, Tsao SW.
    Anticancer Res; 1992 Jul 01; 12(6B):1989-94. PubMed ID: 1363512
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
    Ferguson AW, Svoboda-Newman SM, Frank TS.
    Mod Pathol; 1998 Jan 01; 11(1):11-8. PubMed ID: 9556417
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
    Baser E, Can F, Unlukaplan M, Ayhan A.
    Int J Gynecol Cancer; 2011 Jan 01; 21(1):117-22. PubMed ID: 21330836
    [Abstract] [Full Text] [Related]

  • 55. Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis.
    Nakagawa H, Sugano K, Fujii T, Kubushiro K, Tsukazaki K, Nozawa S.
    Anticancer Res; 2002 Jan 01; 22(3):1655-60. PubMed ID: 12168850
    [Abstract] [Full Text] [Related]

  • 56. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
    Viladiu P, Bosch FX, Castellsagué X, Muñoz N, Escribà JM, Hamsíkova E, Hofmannova V, Guerrero E, Izquierdo A, Navarro C, Moreo P, Izarzugaza I, Ascunce N, Gili M, Muñoz MT, Tafur L, Shah KV, Vonka V.
    J Clin Oncol; 1997 Feb 01; 15(2):610-9. PubMed ID: 9053484
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
    Penhallow J, Steingrimsdottir H, Elamin F, Warnakulasuriya S, Farzaneh F, Johnson N, Tavassoli M.
    Int J Oncol; 1998 Jan 01; 12(1):59-68. PubMed ID: 9454887
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.